Award to SIRTEX MEDICAL, INC.

The Defense Health Agency awarded a firm-fixed-price contract to SIRTEX MEDICAL, INC. under a sole-source determination authorized by FAR 12.102(b), recognizing the company as the sole supplier capable of providing SIR-Spheres (Yttrium-90 Micro Resin Spheres) for emergency radioembolization procedures at Madigan Army Medical Center. The procurement, identified by solicitation number HT941026N0076 and contract number HT941026PE102, was non-competitive due to the unique, irreplaceable nature of the product, which is critical for timely patient care and has no therapeutically equivalent alternatives. The estimated delivery date is July 1, 2026, with the product to be delivered to Madigan Army Medical Center in Joint Base Lewis McChord, Washington, while administrative oversight is managed by the Defense Health Agency’s Healthcare Contracting Division – West located at Camp Pendleton, California. No pricing details, contract value, or CLIN/SLIN structures are provided in the available documentation, indicating the award notice omits financial specifics typically found in Section B. The vendor’s Unique Entity ID is CWH2GM13A2V6 and CAGE code is 45EE6; however, no size status or socioeconomic certifications are disclosed. The solicitation process required offerors to submit a single capability statement not exceeding six pages in 10-point or larger font, submitted electronically via email by July 2, 2026, with no physical submissions permitted. While the contract type is clearly firm-fixed-price, no formal clause listings from Section I, listing of attachments under Section J, packaging and marking requirements under Section D, invoicing mechanisms, or explicit inspection and acceptance criteria are detailed in the provided documents. The award justification relies on the vendor’s exclusive regulatory approvals and proprietary technology, with no competitive evaluation or formal weights applied. Point of contact for the acquisition is Bobbie Dobberstein, with Mariangela Monsalve designated as secondary contact; no Contracting Officer, COR, or COTR is named. The NAICS code assigned is 325412 for Pharmaceutical Preparation Manufacturing, under the Department of Defense, and no payment office, accounting codes, or FOB terms are specified. All requirements are centered around ensuring an uninterrupted supply of a time-sensitive medical product essential for oncology treatment, with the entire process structured around emergency need rather than